Sign inJoin waitlistJoin the waitlist

Ashley Frith

Physician · Washington University School of Medicine

Credentials: · · · · · ·

History

Washington University School of Medicine
Present

Hematology and Medical Oncology
Washington University/B-JH/SLCH Consortium
2011–2014
Internal Medicine
Vanderbilt University Medical Center
2008–2011
Univ of Arkansas Coll of Med
2004–2008
Christian Brothers University, Memphis, TN
2000–2004

Research

Retrospective Analysis of Treatment Patterns and Effectiveness of Palbociclib and Subsequent Regimens in Metastatic Breast Cancer
Journal of the National Comprehensive Cancer Network · 2019 · 74 citations
Genomic Complexity Predicts Resistance to Endocrine Therapy and CDK4/6 Inhibition in Hormone Receptor-Positive (HR+)/HER2-Negative Metastatic Breast Cancer
Clinical Cancer Research · 2023 · 37 citations
Immunogenomic profiling and pathological response results from a clinical trial of docetaxel and carboplatin in triple-negative breast cancer
Breast Cancer Research and Treatment · 2021 · 33 citations

CM
Cynthia Ma
9 papers
Foluso Ademuyiwa
9 papers
RS
Rama Suresh
9 papers
Katherine Weilbaecher
7 papers
CR
Caron Rigden
6 papers
Katherine Clifton
6 papers
Leonel Aya
6 papers
LP
Lindsay Peterson
5 papers
NB
Nusayba Bagegni
4 papers
RB
Ron Bose
4 papers
Anna Roshal
3 papers
Ian Hagemann
3 papers

Clinical trials

Combination Liposomal Irinotecan and Pembrolizumab For Triple-Negative Breast Cancer (TNBC) With Brain Metastases (BM)
Principal investigator · Withdrawn · Phase 2
Washington University School of Medicine
2023–2030
Zunsemetinib in Combination With Capecitabine in Patients With Hormone Receptor-Positive and HER2-Negative Metastatic Breast Cancer With Bone Metastasis
Sub-investigator · Recruiting · Phase 1, Phase 2
Washington University School of Medicine
2025–2032
Treatment Monitoring of Patients Receiving CDK 4/6 Inhibitors for Hormone Receptor (HR) Positive, HER2 Negative Metastatic Breast Cancer (MBC) With or Without the Addition of DiviTum® Serum Thymidine Kinase 1 (TK1) Activity Testing
Sub-investigator · Recruiting
Washington University School of Medicine
2022–2030
Endocrine Treatment Alone for Elderly Patients With Estrogen Receptor Positive Operable Breast Cancer and Low Recurrence Score
Sub-investigator · Recruiting · Phase 2
Washington University School of Medicine
2017–2032